ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2013

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.

Shekoufeh Nikfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.